In the month of April, Serra Capital II has invested in three new companies, OceanComm, Personify, and Nanomedical Diagnostics. The Serra Capital II portfolio now totals 25 companies.
Tim Hoerr, managing partner of Serra II, enthuse “The Serra Capital team is pleased to support three distinctive companies, each representing a unique opportunity for our Fund. Personify has been a Serra Capital I company for several years. They are bringing cutting edge telepresence technology to the market and have made tremendous progres. Nanomedical Diagnostics is developing exceptional diagnostic tools with an initial focus on Lyme disease. And OceanComm represents an emerging communications technology developed by a seasoned team with both research and commercialization experience. All three of these opportunities exemplify the characteristics that Serra Capital seeks as we build a portfolio to produce exceptional investor returns.”